Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
09 03 2022
Historique:
received: 09 03 2021
pubmed: 4 6 2021
medline: 16 3 2022
entrez: 3 6 2021
Statut: ppublish

Résumé

We report a case of resistance development toward cefiderocol in a patient with intra-abdominal and bloodstream infections caused by carbapenemase-producing Enterobacter cloacae within 21 days of cefiderocol therapy. Whole genome sequencing revealed heterogeneous mutations in the cirA gene, encoding a catecholate siderophore receptor, conferring phenotypic resistance to cefiderocol.

Identifiants

pubmed: 34079986
pii: 6291426
doi: 10.1093/cid/ciab511
pmc: PMC8906715
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Carbapenems 0
Cephalosporins 0
Siderophores 0
beta-Lactamases EC 3.5.2.6

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

905-908

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S519-S520
pubmed: 31724046
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32284381
J Antimicrob Chemother. 2020 Jul 1;75(7):1840-1849
pubmed: 32277821
Clin Infect Dis. 2020 Dec 17;71(10):2713-2716
pubmed: 32236408
Diagn Microbiol Infect Dis. 2019 Aug;94(4):321-325
pubmed: 31029489
Antimicrob Agents Chemother. 2020 Nov 17;64(12):
pubmed: 32958717
J Bacteriol. 1990 Mar;172(3):1361-7
pubmed: 2407721
Open Forum Infect Dis. 2018 Jun 28;5(7):ofy150
pubmed: 30046639
Clin Infect Dis. 2021 Jun 15;72(12):e1103-e1111
pubmed: 33393598
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29061741
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S538-S543
pubmed: 31724047
Int J Antimicrob Agents. 2019 Feb;53(2):177-184
pubmed: 30395986
Int J Antimicrob Agents. 2017 Aug;50(2):127-134
pubmed: 28647532
Clin Microbiol Infect. 2020 Jun;26(6):780.e1-780.e8
pubmed: 31654794

Auteurs

Sabrina Klein (S)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg,Germany.

Sébastien Boutin (S)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg,Germany.

Kaan Kocer (K)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg,Germany.

Mascha O Fiedler (MO)

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg,Germany.

Dominic Störzinger (D)

Pharmacy Department, Heidelberg University Hospital, Heidelberg, Germany.

Markus A Weigand (MA)

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg,Germany.

Benjamin Tan (B)

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg,Germany.

Daniel Richter (D)

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg,Germany.

Christian Rupp (C)

Department of Internal Medicine IV, Heidelberg University Hospital, Heidelberg, Germany.

Markus Mieth (M)

Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.

Arianeb Mehrabi (A)

Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.

Thilo Hackert (T)

Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.

Stefan Zimmermann (S)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg,Germany.

Klaus Heeg (K)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg,Germany.

Dennis Nurjadi (D)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg,Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH